|
|
|
Megan Chacon, a principal at Fish & Richardson and a member of the firm’s life sciences industry team, answers questions about what a second Trump administration could mean for biopharmaceutical IP and drug patents. |
|
|
|
| Maturity Model For Clinical Trial Disclosure | Is your organization seeking to improve its disclosure and transparency practices? Learn about the eight key domains that are assessed by the clinical trial disclosure maturity model. |
|
|
| 5 Tips To Improve Patient Education | Effective patient education fosters better health outcomes, emphasizing trust, and tailored materials, while innovative tools enhance comprehension, empowering patients to manage their health. |
|
|
| A Guide To Protein Engineering | Almost every facet of an antibody can be modified. Explore antibody humanization, the importance of affinity and function, isotype selection, and the development of bispecific and antibody-drug conjugates. |
|
|
|
|
|
CONTRIBUTE TO LIFE SCIENCE LEADER |
|
|
|
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. |
|
|